Skip to content

Abbott profit halved, hit by high costs

July 20, 2017

Diversified healthcare company Abbott Laboratories (NYSE: ABT) reported a 55 percent drop in quarterly profit on Thursday, hurt by higher costs.

The company’s net profit from continuing operations fell to $270 million, or 15 cents per share, in the second quarter ended June 30 from $599 million, or 40 cents per share, a year earlier.

Total operating cost and expenses surged 37.5 percent to $6.21 billion.

However, net sales rose to $6.64 billion from $5.33 billion.

Abbott, which closed its $25 billion acquisition of St. Jude Medical in January, agreed to buy troubled diagnostics company Alere Inc (NYSE: ALR) for a revised value of $5.30 billion in April.


From → Uncategorized

Leave a Comment

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

%d bloggers like this: